Search - Université Clermont Auvergne Access content directly

Filter your results

11 Results
authFullName_s : Anne Banos

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial

Anne Bouvier , Jean-Francois Hamel , Jacques Delaunay , Eric Delabesse , Pierre-Yves Dumas et al.
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
Journal articles hal-03604930v1

A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone

Véronique Leblond , Pierre Morel , Marie-Sarah Dilhuidy , Xavier Leleu , Carole Soussain et al.
Leukemia & lymphoma, 2017, 58 (11), pp.2615 - 2623. ⟨10.1080/10428194.2017.1307357⟩
Journal articles hal-01655961v1

Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study

Guillaume Cartron , Remi Letestu , Caroline Dartigeas , Mira Tout , Beatrice Mahe et al.
Haematologica, 2018, 103 (8), pp.e356 - e359. ⟨10.3324/haematol.2017.182352⟩
Journal articles hal-01860398v1

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laetitia Largeaud , Pascale Cornillet-Lefebvre , Jean-François Hamel , Pierre-Yves Dumas , Naïs Prade et al.
Leukemia, 2021, 35 (5), pp.1291-1300. ⟨10.1038/s41375-020-01031-1⟩
Journal articles hal-03441014v1

Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO Trial

Arnaud Pigneux , Marie Béné , Louis-Rachid Salmi , Pierre-Yves Dumas , Jacques Delaunay et al.
Journal of Clinical Oncology, 2018, 36 (32), pp.3203-3210. ⟨10.1200/JCO.2018.78.7366⟩
Journal articles hal-02874606v1
Image document

Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial

Anne-Sophie Michallet , Marie-Sarah Dilhuydy , Fabien Subtil , Valérie Rouillé , Béatrice Mahé et al.
The Lancet Haematology, 2019, 6 (9), pp.e470-e479. ⟨10.1016/S2352-3026(19)30113-9⟩
Journal articles hal-02299505v1
Image document

miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study.

Anne-Laure Gagez , Isabelle Duroux-Richard , Stéphane Leprêtre , Frédérique Orsini-Piocelle , Rémi Letestu et al.
Haematologica, 2017, 102 (4), pp.746-754. ⟨10.3324/haematol.2016.153189⟩
Journal articles hal-01568353v1
Image document

A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Norbert Schmitz , Lorenz Truemper , Krimo Bouabdallah , Marita Ziepert , Mathieu Leclerc et al.
Blood, 2021, 2020008825, ⟨10.1182/blood.2020008825⟩
Journal articles hal-03163608v1
Image document

R-CHOP 14 with or without radiotherapy in non-bulky limited-stage diffuse large B-cell lymphoma (DLBCL)

Thierry Lamy , Gandhi Damaj , Pierre Soubeyran , Emmanuel Gyan , Guillaume Cartron et al.
Blood, 2018, 131 (2), pp.174-181. ⟨10.1182/blood-2017-07-793984⟩
Journal articles hal-01635792v1

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Arnaud Pigneux , Christian Récher , Marie C. Bene , Julien Asselineau , Ariane C. Mineur et al.
Blood, 2015, 126 (23)
Journal articles hal-01295674v1
Image document

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laetitia Largeaud , Pascale Cornillet-Lefebvre , Jean-François Hamel , Pierre-Yves Dumas , Naïs Prade et al.
Leukemia, 2021, 35 (5), pp.1291-1300. ⟨10.1038/s41375-020-01031-1⟩
Journal articles hal-03623649v1